Hakim Bouterfa
Directeur Général chez PentixaPharm GmbH
Profil
Hakim Larbi Bouterfa is the founder of OctreoPharm Sciences GmbH, which was founded in 2009.
He held the title of Chief Executive Officer from 2010 to 2013.
He is currently the Co-Managing Director at PentixaPharm GmbH and the Managing Partner at 1717 Life Sciences Ventures GmbH, both of which are his current jobs.
In his former positions, he worked as the Medical Director-Sandostatin Franchise at Novartis Pharma GmbH and as the Managing Director & VP-European Operations at Molecular Insight Pharmaceuticals GmbH.
He also served as the Chief Medical Officer at Eckert & Ziegler SE in 2023.
Postes actifs de Hakim Bouterfa
| Sociétés | Poste | Début |
|---|---|---|
| 1717 Life Sciences Ventures GmbH | Private Equity Investor | 01/01/2017 |
PentixaPharm GmbH
 PentixaPharm GmbH Miscellaneous Commercial ServicesCommercial Services Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Directeur Général | - |
Anciens postes connus de Hakim Bouterfa
| Sociétés | Poste | Fin |
|---|---|---|
| ECKERT & ZIEGLER SE | Directeur Technique/Scientifique/R&D | 31/12/2023 |
Molecular Insight Pharmaceuticals GmbH
 Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of Lantheus Holdings, Inc., Molecular Insight Pharmaceuticals GmbH develops and commercializes innovative molecular imaging pharmaceuticals. The company is based in Wuerzburg, Germany. | Directeur Général | - |
Novartis Pharma GmbH
 Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
 OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ECKERT & ZIEGLER SE | Health Technology |
| Entreprise privées | 5 |
|---|---|
OctreoPharm Sciences GmbH
OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Health Technology |
Molecular Insight Pharmaceuticals GmbH
Molecular Insight Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Part of Lantheus Holdings, Inc., Molecular Insight Pharmaceuticals GmbH develops and commercializes innovative molecular imaging pharmaceuticals. The company is based in Wuerzburg, Germany. | Health Technology |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Health Technology |
| 1717 Life Sciences Ventures GmbH | Finance |
PentixaPharm GmbH
PentixaPharm GmbH Miscellaneous Commercial ServicesCommercial Services Pentixapharm GmbH engages in the development, production, marketing, and distribution of medicines and radiopharmaceutical products, which act on the CXCR4 receptor. The company was founded on May 14, 2019 and is headquartered in Wuerzburg, Germany. | Commercial Services |